[1] MARON B J, DESAI M Y, NISHIMURA R A, et al. Management of Hypertrophic Cardiomyopathy[J]. J Am Coll Cardiol, 2022, 79(4):390-414. [2] MEMBERS W C, OMMEN S R, MITAL S, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy[J]. Circulation, 2020, 142(25):533-537. [3] SCOTTI M M, SWANSON M S. RNA mis-splicing in disease[J]. Nat Rev Genet, 2016, 17(1):19-32. [4] PARK E, PAN Z C, ZHANG Z J, et al. The expanding landscape of alternative splicing variation in human populations[J]. Am J Hum Genet, 2018, 102(1):11-26. [5] ITO K, PATEL P N, GORHAM J M, et al. Identification of pathogenic gene mutations in LMNA and MYBPC3 that alter RNA splicing[J]. Proc Natl Acad Sci U S A, 2017, 114(29):7689-7694. [6] SINGER E S, INGLES J, SEMSARIAN C, et al. Key value of RNA analysis of MYBPC3 splice-site variants in hypertrophic cardiomyopathy[J]. Circ Genom Precis Med, 2019, 12(1):e002368. [7] PATEL P N, ITO K, WILLCOX J A L, et al. Contribution of noncanonical splice variants to TTN truncating variant cardiomyopathy[J]. Circ Genom Precis Med, 2021, 14(5):e003389. [8] LI K K, LUO T F, ZHU Y, et al. Performance evaluation of differential splicing analysis methods and splicing analytics platform construction[J]. Nucleic Acids Res, 2022, 50(16):9115-9126. [9] LIU H, DAI J Q, LI K, et al. Performance evaluation of computational methods for splice-disrupting variants and improving the performance using the machine learning-based framework[J]. Brief Bioinform, 2022, 23(5):bbac334. [10] ROWLANDS C, THOMAS H B, LORD J, et al. Comparison of in silico strategies to prioritize rare genomic variants impacting RNA splicing for the diagnosis of genomic disorders[J]. Sci Rep, 2021, 11(1):20607. [11] RIEPE T V, KHAN M, ROOSING S, et al. Benchmarking deep learning splice prediction tools using functional splice assays[J]. Hum Mutat, 2021, 42(7):799-810. [12] SOEMEDI R, CYGAN K J, RHINE C L, et al. Pathogenic variants that alter protein code often disrupt splicing[J]. Nat Genet, 2017, 49(6):848-855. [13] ZHANG Q, FAN X D, WANG Y J, et al. BPP:a sequencebased algorithm for branch point prediction[J]. Bioinformatics, 2017, 33(20):3166-3172. [14] RENTZSCH P, SCHUBACH M, SHENDURE J, et al. CADDSplice-improving genome-wide variant effect prediction using deep learning-derived splice scores[J]. Genome Med, 2021, 13(1):31. [15] JIAN X Q, BOERWINKLE E, LIU X M. In silico prediction of splice-altering single nucleotide variants in the human genome[J]. Nucleic Acids Res, 2014, 42(22):13534-13544. [16] PAGGI J M, BEJERANO G. A sequence-based, deep learning model accurately predicts RNA splicing branchpoints[J]. RNA, 2018, 24(12):1647-1658. [17] YEO G, BURGE C B. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals[J]. J Comput Biol, 2004, 11(2/3):377-394. [18] CHENG J, NGUYEN T Y D, CYGAN K J, et al. MMSplice:modular modeling improves the predictions of genetic variant effects on splicing[J]. Genome Biol, 2019, 20(1):48. [19] ZENG T, LI Y I. Predicting RNA splicing from DNA sequence using Pangolin[J]. Genome Biol, 2022, 23(1):103. [20] LIN H, HARGREAVES K A, LI R D, et al. RegSNPs-intron:a computational framework for predicting pathogenic impact of intronic single nucleotide variants[J]. Genome Biol, 2019, 20(1):254. [21] NAZARI I, TAYARA H, CHONG K T. Branch point selection in RNA splicing using deep learning[J]. IEEE Access, 1800, 7:1800-1807. [22] JAGADEESH K A, PAGGI J M, YE J S, et al. S-CAP extends pathogenicity prediction to genetic variants that affect RNA splicing[J]. Nat Genet, 2019, 51(4):755-763. [23] XIONG H Y, ALIPANAHI B, LEE L J, et al. RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease[J]. Science, 2015, 347(6218):1254806. [24] JAGANATHAN K, KYRIAZOPOULOU PANAGIOTOPOULOU S, MCRAE J F, et al. Predicting splicing from primary sequence with deep learning[J]. Cell, 2019, 176(3):535-548.e24. [25] MONGER S, TROUP M, IP E, et al. Spliceogen:an integrative, scalable tool for the discovery of splice-altering variants[J]. Bioinformatics, 2019, 35(21):4405-4407. [26] DANIS D, JACOBSEN J O B, CARMODY L C, et al. Interpretable prioritization of splice variants in diagnostic next-generation sequencing[J]. Am J Hum Genet, 2021, 108(11):2205. [27] CHICCO D, JURMAN G. The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation[J]. BMC Genomics, 2020, 21(1):6. [28] LEK M, KARCZEWSKI K J, MINIKEL E V, et al. Analysis of protein-coding genetic variation in 60, 706 humans[J]. Nature, 2016, 536(7616):285-291. |